Scott J. Antonia, MD, PhD
Articles
Propelling Immunotherapy Combinations Into the Clinic
Nishan Tchekmedyian, MD;Jhanelle E. Gray, MD;Benjamin C. Creelan, MD;Alberto A. Chiappori, MD;Amer A. Beg, PhD;Hatem Soliman, MD;Bradford A. Perez, MD;Scott J. Antonia, MD, PhD
December 16th 2015This review summarizes promising new targets and immunotherapy combination strategies currently under clinical development.
Adapting to the Brave New World of Lung Cancer Treatment
May 15th 2013If we are to provide new options for the large numbers of NSCLC patients with no actionable mutation, we must focus on identifying new mutations through tissue acquisition. In the meantime, these patients are ideal candidates for the large number of available immunotherapy trials.
Latest Updated Articles
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Published: August 19th 2019 | Updated: November 21st 2024
A 22-Year-Old Woman With Pain, Tenderness and Swelling in the Breast
Published: July 29th 2015 | Updated: November 21st 2024
Liver Abnormality in 28-Year-Old Patient
Published: November 8th 2024 | Updated: November 21st 2024
The Hidden Danger Unveiling the Connection Between Multiple Myeloma and Pleural Effusion
